Charlotte’s Web - Our Company

Charlotte’s Web, is an industry-leading pioneer creating whole-plant hemp health supplements. A vertically integrated company, every step of the process is overseen to ensure the highest quality, from seed to self.

Charlotte's Web's mission is to unleash the healing powers of botanicals with compassion and science, benefitting the planet and all who live upon it. We do this by responsibly growing our proprietary non-GMO hemp genetics on family farms that are made into premium, full-spectrum phytocannabinoid health and wellness products. Charlotte’s Web is manufactured in America's first "hemp-only" NSF cGMP (Good Manufacturing Practices) registered facility for dietary supplements.

CHARLOTTE’S WEB HISTORY

2011

Proprietary Hemp

Stanley Brothers develop proprietary hemp genetics that would later become the basis of Charlotte's Web products.

2012

Enter Charlotte Figi

Charlotte’s mother Paige Figi contacts the SB looking for non-intoxicating natural alternative for her 5 year old daughter.

2013

Global Media Explosion

Dr. Sanjay Gupta, Chief Medical Correspondant, CNN meets Charlotte and other families and famously changes his opinion; reversing and speaking in favor of Charlotte's Web and the inherent benefits of cannabinoids. Other media outlets follow suit and CW becomes an internationally recognized brand.

2014

A New Age of Hemp

US Farm Bill Sc 7606 defines industrial hemp as containing less than 0.3% THC. The Colorado dept. of Agriculture tests and licenses CW as industrial hemp thus allowing for its mass cultivation in the US.

2015

Charlotte's First Day

Charlotte goes to school for the very first time ever.

2016

Company Growth

CW launches new products, new brand.packaging and a new website. New hires and expanded departments help maximize production.

2018

Charlotte's Web IPO

CW closes their Initial Public Offering and lists on the Canadian Stock Exchange. The first long-form prospectus offering for a US cannabidiol company.

2019

Company Growth

CW sales grow to $95M with distribution through 10,000 retail doors

2020

Market Leadership

CW acquires Abacus Health, leader in over-the-counter CBD topical products, resulting in 35% market share of U.S food and drug mass retail channel and more than 21,000 unique retail doors combined.